Integración de la atención a las enfermedades cardiovasculares, renales y metabólicas

12:30 PM – 1:30 PM – SESSION 6

Integración de la atención a las enfermedades cardiovasculares, renales y metabólicas

Integración de la atención a las enfermedades cardiovasculares, renales y metabólicas

Puntos destacados de la sesión

In this WHF Heart Café conversation, moderator Larry Sperling (Emory) hosts Andrés Rosende (PAHO/HEARTS in the Americas), Tazeen Jafar (Duke–NUS/Duke), and Naveed Sattar (University of Glasgow) to unpack integrated care across Cardio-Kidney-Metabolic (CKM) disease. The panel explores the interconnectedness of cardiovascular, kidney, and metabolic conditions; the rising burden from obesity and diabetes; scalable primary-care solutions like HEARTS clinical pathways; team-based and community models; and how digital health/AI, prevention policy (food environment), and climate risks can be addressed to make care more comprehensive, equitable, and effective.

Principales conclusiones

CKM is one system

Cardiovascular, kidney, and metabolic diseases share pathophysiology and risks; siloed guidelines miss multimorbidity and real-world needs.

Epidemiology is shifting

Obesity/diabetes are accelerating CKM burden at younger ages; social determinants and ultra-processed food environments amplify risk.

From guidelines to pathways

HEARTS-style integrated clinical pathways (simple ≠ simplistic) help primary care deliver consistent BP, lipids, diabetes, vaccination, and CKD care.

Team-based, community care works

Task-sharing with nurses and community health workers, kiosks, and telehealth builds access and trust in LMICs and remote settings.

AI as co-pilot

Use AI decision support to personalize therapy and close gaps—always with human oversight and local adaptation.

Climate & infections matter

Heat stress, pollution, toxins, and infectious-disease links raise CKM risk; include vaccination and resilience planning in pathways.

Best buy = prevention & policy

Advocate for healthier food environments, activity-friendly cities, and early-life prevention alongside scalable primary-care protocols.

¿Quién debe verlo?

Cardiologists, nephrologists, endocrinologists, GPs, nurses, pharmacists, public-health leaders, payers, digital-health teams, environmental-health experts, and community advocates building integrated CKM care, HEARTS-aligned primary care, and prevention policy.

Sesión CKM - FAQ

¿Qué es la CKM y por qué es importante integrarla?

CKM (Cardio-Kidney-Metabolic) reflects shared risks (obesity, hypertension, diabetes, inflammation). Integrated pathways manage multimorbidity better than single-disease silos.

¿Cómo mejora HEARTS en las Américas los resultados?

By standardizing primary-care clinical pathways (BP, lipids, diabetes, CKD, vaccines), enabling team-based task-sharing, and simplifying protocols for scale-up and equity.

¿Es la IA la respuesta para la atención a los enfermos crónicos?

AI is a useful co-pilot for risk stratification and therapy choice, but success requires human intelligence, local workflows, training, and community trust.

¿Cómo afectan el clima y el medio ambiente a la CKM?

Heat, pollution, flooding, and toxins increase AKI/CKD and CV risk. Build climate-resilient care (cooling, water, supply chains), vaccination, and clean-air advocacy into CKM plans.